Differential effects of LHRH and somatostatin analogs on human breast cancer
- 31 January 1992
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 52 (1), 6-14
- https://doi.org/10.1016/0022-4804(92)90271-z
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Suppression of Postmenopausal Ovarian Steroidogenesis With the Luteinizing Hormone-Releasing Hormone Agonist Goserelin*Journal of Clinical Endocrinology & Metabolism, 1988
- Histologic changes in the rat prostate cancer model after treatment with somatostatin analogs and D‐Trp‐6‐LH‐RHThe Prostate, 1988
- Cultured mammary carcinoma cells contain gonadotropin‐releasing hormone‐like immunoreactivity, gnrh binding sites and chorionic gonadotropinInternational Journal of Cancer, 1987
- Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630British Journal of Cancer, 1986
- Mechanism of Action of Gonadotropin Releasing HormoneAnnual Review of Physiology, 1986
- The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancerBritish Journal of Cancer, 1986
- Gonadotropin-Releasing Hormone Binding Sites in Human Breast CarcinomaScience, 1985
- Chapter 21. Luteinizing Hormone Releasing Hormone (LHRH) AnaloguesPublished by Elsevier ,1985
- Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancerBreast Cancer Research and Treatment, 1984
- Use of analogues of luteinizing hormone-releasing hormone for the treatment of cancerReproduction, 1982